These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7069550)

  • 41. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
    Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between inflammation, alpha-1-acid glycoprotein and lidocaine tolerance during fiber-optic bronchoscopy.
    Philip-Joet F; Bruguerolle B; Arnaud C; Arnaud A
    Respiration; 1987; 51(1):68-72. PubMed ID: 3563124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severity of cirrhosis and the relationship of alpha 1-acid glycoprotein concentration to plasma protein binding of lidocaine.
    Barry M; Keeling PW; Weir D; Feely J
    Clin Pharmacol Ther; 1990 Mar; 47(3):366-70. PubMed ID: 2311337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum alpha 1-acid glycoprotein and the binding of drugs in obesity.
    Benedek IH; Fiske WD; Griffen WO; Bell RM; Blouin RA; McNamara PJ
    Br J Clin Pharmacol; 1983 Dec; 16(6):751-4. PubMed ID: 6661365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dosage regimens of antiarrhythmics. 1. Pharmacokinetic properties.
    Levy RH; Smith GH
    Am J Hosp Pharm; 1973 May; 30(5):398-404. PubMed ID: 4704419
    [No Abstract]   [Full Text] [Related]  

  • 46. Human albumin and alpha 1-acid glycoprotein binding of propranolol in the presence of a perfluorochemical blood substitute.
    Parsons DL; Shih RL
    Arch Int Pharmacodyn Ther; 1989; 297():294-304. PubMed ID: 2730240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic drug monitoring of antiarrhythmic agents.
    Brown JE; Shand DG
    Clin Pharmacokinet; 1982; 7(2):125-48. PubMed ID: 7039925
    [No Abstract]   [Full Text] [Related]  

  • 48. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum alpha-1-acid glycoprotein (orosomucoid) in uremic patients on hemodialysis.
    Henriksen HJ; Petersen MU; Pedersen FB
    Nephron; 1982; 31(1):24-6. PubMed ID: 7110472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lidocaine plasma protein binding.
    Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
    Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha 1-acid glycoprotein and the binding of lidocaine in children with congenital heart disease.
    Burrows FA; Lerman J; LeDez KM; Strong HA
    Can J Anaesth; 1990 Nov; 37(8):883-8. PubMed ID: 1701361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of antiarrhythmic drugs to purified human alpha 1-acid glycoprotein.
    Gillis AM; Yee YG; Kates RE
    Biochem Pharmacol; 1985 Dec; 34(24):4279-82. PubMed ID: 4074387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alpha 1-acid glycoprotein and carbamazepine].
    Bruguerolle B; Bussière H; Jadot G
    Rev Neurol (Paris); 1983; 139(11):679-80. PubMed ID: 6677980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alteration in plasma protein binding properties of propranolol and flurbiprofen during development of adjuvant-induced arthritis in rats.
    Kawase A; Ikuta H; Uno S; Yamamoto K; Akitsu N; Nagao T; Iwaki M
    Xenobiotica; 2013 Mar; 43(3):246-52. PubMed ID: 22867272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of oxprenolol and propranolol to serum, albumin and alpha 1-acid glycoprotein in man and other species.
    Belpaire FM; Braeckman RA; Bogaert MG
    Biochem Pharmacol; 1984 Jul; 33(13):2065-9. PubMed ID: 6743355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Auramine O as a fluorescent probe for the binding of basic drugs to human alpha 1-acid glycoprotein (alpha 1-AG). The development of a simple fluorometric method for the determination of alpha 1-AG in human serum.
    Sugiyama Y; Suzuki Y; Sawada Y; Kawasaki S; Beppu T; Iga T; Hanano M
    Biochem Pharmacol; 1985 Mar; 34(6):821-9. PubMed ID: 3977957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma drug binding: implications for anesthesiologists.
    Wood M
    Anesth Analg; 1986 Jul; 65(7):786-804. PubMed ID: 3087239
    [No Abstract]   [Full Text] [Related]  

  • 59. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG).
    McNamara PJ; Brouwer KR; Gillespie MN
    Biochem Pharmacol; 1986 Feb; 35(4):621-4. PubMed ID: 3947392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.